Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome. / Charbonneau, Bridget; Moysich, Kirsten B; Kalli, Kimberly R; Oberg, Ann L; Vierkant, Robert A; Fogarty, Zachary C; Block, Matthew S; Maurer, Matthew J; Goergen, Krista M; Fridley, Brooke L; Cunningham, Julie M; Rider, David N; Preston, Claudia; Hartmann, Lynn C; Lawrenson, Kate; Wang, Chen; Tyrer, Jonathan; Song, Honglin; deFazio, Anna; Johnatty, Sharon E; Doherty, Jennifer A; Phelan, Catherine M; Sellers, Thomas A; Ramirez, Starr M; Vitonis, Allison F; Terry, Kathryn L; Van Den Berg, David; Pike, Malcolm C; Wu, Anna H; Berchuck, Andrew; Gentry-Maharaj, Aleksandra; Ramus, Susan J; Diergaarde, Brenda; Shen, Howard; Jensen, Allan; Menkiszak, Janusz; Cybulski, Cezary; Lubiłski, Jan; Ziogas, Argyrios; Rothstein, Joseph H; McGuire, Valerie; Sieh, Weiva; Lester, Jenny; Walsh, Christine; Vergote, Ignace; Lambrechts, Sandrina; Despierre, Evelyn; Garcia-Closas, Montserrat; Hogdall, Claus K; Kjaer, Susanne K; AOCS Group.

I: Cancer Immunology Research (CIR), Bind 2, Nr. 4, 04.2014, s. 332-340.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Charbonneau, B, Moysich, KB, Kalli, KR, Oberg, AL, Vierkant, RA, Fogarty, ZC, Block, MS, Maurer, MJ, Goergen, KM, Fridley, BL, Cunningham, JM, Rider, DN, Preston, C, Hartmann, LC, Lawrenson, K, Wang, C, Tyrer, J, Song, H, deFazio, A, Johnatty, SE, Doherty, JA, Phelan, CM, Sellers, TA, Ramirez, SM, Vitonis, AF, Terry, KL, Van Den Berg, D, Pike, MC, Wu, AH, Berchuck, A, Gentry-Maharaj, A, Ramus, SJ, Diergaarde, B, Shen, H, Jensen, A, Menkiszak, J, Cybulski, C, Lubiłski, J, Ziogas, A, Rothstein, JH, McGuire, V, Sieh, W, Lester, J, Walsh, C, Vergote, I, Lambrechts, S, Despierre, E, Garcia-Closas, M, Hogdall, CK, Kjaer, SK & AOCS Group 2014, 'Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome', Cancer Immunology Research (CIR), bind 2, nr. 4, s. 332-340. https://doi.org/10.1158/2326-6066.CIR-13-0136

APA

Charbonneau, B., Moysich, K. B., Kalli, K. R., Oberg, A. L., Vierkant, R. A., Fogarty, Z. C., Block, M. S., Maurer, M. J., Goergen, K. M., Fridley, B. L., Cunningham, J. M., Rider, D. N., Preston, C., Hartmann, L. C., Lawrenson, K., Wang, C., Tyrer, J., Song, H., deFazio, A., ... AOCS Group (2014). Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome. Cancer Immunology Research (CIR), 2(4), 332-340. https://doi.org/10.1158/2326-6066.CIR-13-0136

Vancouver

Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC o.a. Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome. Cancer Immunology Research (CIR). 2014 apr.;2(4):332-340. https://doi.org/10.1158/2326-6066.CIR-13-0136

Author

Charbonneau, Bridget ; Moysich, Kirsten B ; Kalli, Kimberly R ; Oberg, Ann L ; Vierkant, Robert A ; Fogarty, Zachary C ; Block, Matthew S ; Maurer, Matthew J ; Goergen, Krista M ; Fridley, Brooke L ; Cunningham, Julie M ; Rider, David N ; Preston, Claudia ; Hartmann, Lynn C ; Lawrenson, Kate ; Wang, Chen ; Tyrer, Jonathan ; Song, Honglin ; deFazio, Anna ; Johnatty, Sharon E ; Doherty, Jennifer A ; Phelan, Catherine M ; Sellers, Thomas A ; Ramirez, Starr M ; Vitonis, Allison F ; Terry, Kathryn L ; Van Den Berg, David ; Pike, Malcolm C ; Wu, Anna H ; Berchuck, Andrew ; Gentry-Maharaj, Aleksandra ; Ramus, Susan J ; Diergaarde, Brenda ; Shen, Howard ; Jensen, Allan ; Menkiszak, Janusz ; Cybulski, Cezary ; Lubiłski, Jan ; Ziogas, Argyrios ; Rothstein, Joseph H ; McGuire, Valerie ; Sieh, Weiva ; Lester, Jenny ; Walsh, Christine ; Vergote, Ignace ; Lambrechts, Sandrina ; Despierre, Evelyn ; Garcia-Closas, Montserrat ; Hogdall, Claus K ; Kjaer, Susanne K ; AOCS Group. / Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome. I: Cancer Immunology Research (CIR). 2014 ; Bind 2, Nr. 4. s. 332-340.

Bibtex

@article{382bf669f3554d1c8c1ac6c9b4f1f7a3,
title = "Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome",
abstract = "The presence of regulatory T cells (Treg) in solid tumors is known to play a role in patient survival in ovarian cancer and other malignancies. We assessed inherited genetic variations via 749 tag single-nucleotide polymorphisms (SNP) in 25 Treg-associated genes (CD28, CTLA4, FOXP3, IDO1, IL10, IL10RA, IL15, 1L17RA, IL23A, IL23R, IL2RA, IL6, IL6R, IL8, LGALS1, LGALS9, MAP3K8, STAT5A, STAT5B, TGFB1, TGFB2, TGFB3, TGFBR1, TGRBR2, and TGFBR3) in relation to ovarian cancer survival. We analyzed genotype and overall survival in 10,084 women with invasive epithelial ovarian cancer, including 5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous carcinoma cases of European descent across 28 studies from the Ovarian Cancer Association Consortium (OCAC). The strongest associations were found for endometrioid carcinoma and IL2RA SNPs rs11256497 [HR, 1.42; 95% confidence interval (CI), 1.22-1.64; P = 5.7 × 10(-6)], rs791587 (HR, 1.36; 95% CI, 1.17-1.57; P = 6.2 × 10(-5)), rs2476491 (HR, = 1.40; 95% CI, 1.19-1.64; P = 5.6 × 10(-5)), and rs10795763 (HR, 1.35; 95% CI, 1.17-1.57; P = 7.9 × 10(-5)), and for clear cell carcinoma and CTLA4 SNP rs231775 (HR, 0.67; 95% CI, 0.54-0.82; P = 9.3 × 10(-5)) after adjustment for age, study site, population stratification, stage, grade, and oral contraceptive use. The rs231775 allele associated with improved survival in our study also results in an amino acid change in CTLA4 and previously has been reported to be associated with autoimmune conditions. Thus, we found evidence that SNPs in genes related to Tregs seem to play a role in ovarian cancer survival, particularly in patients with clear cell and endometrioid epithelial ovarian cancer.",
keywords = "Female, Gene Expression, Gene Expression Profiling, Genetic Predisposition to Disease, Genetic Variation, Germ-Line Mutation, Humans, Interleukin-2 Receptor alpha Subunit, Neoplasm Grading, Neoplasm Invasiveness, Ovarian Neoplasms, Patient Outcome Assessment, Polymorphism, Single Nucleotide, Prognosis, T-Lymphocytes, Regulatory",
author = "Bridget Charbonneau and Moysich, {Kirsten B} and Kalli, {Kimberly R} and Oberg, {Ann L} and Vierkant, {Robert A} and Fogarty, {Zachary C} and Block, {Matthew S} and Maurer, {Matthew J} and Goergen, {Krista M} and Fridley, {Brooke L} and Cunningham, {Julie M} and Rider, {David N} and Claudia Preston and Hartmann, {Lynn C} and Kate Lawrenson and Chen Wang and Jonathan Tyrer and Honglin Song and Anna deFazio and Johnatty, {Sharon E} and Doherty, {Jennifer A} and Phelan, {Catherine M} and Sellers, {Thomas A} and Ramirez, {Starr M} and Vitonis, {Allison F} and Terry, {Kathryn L} and {Van Den Berg}, David and Pike, {Malcolm C} and Wu, {Anna H} and Andrew Berchuck and Aleksandra Gentry-Maharaj and Ramus, {Susan J} and Brenda Diergaarde and Howard Shen and Allan Jensen and Janusz Menkiszak and Cezary Cybulski and Jan Lubi{\l}ski and Argyrios Ziogas and Rothstein, {Joseph H} and Valerie McGuire and Weiva Sieh and Jenny Lester and Christine Walsh and Ignace Vergote and Sandrina Lambrechts and Evelyn Despierre and Montserrat Garcia-Closas and Hogdall, {Claus K} and Kjaer, {Susanne K} and {AOCS Group}",
year = "2014",
month = apr,
doi = "10.1158/2326-6066.CIR-13-0136",
language = "English",
volume = "2",
pages = "332--340",
journal = "Cancer Immunology Research",
issn = "2326-6066",
publisher = "American Association for Cancer Research",
number = "4",

}

RIS

TY - JOUR

T1 - Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

AU - Charbonneau, Bridget

AU - Moysich, Kirsten B

AU - Kalli, Kimberly R

AU - Oberg, Ann L

AU - Vierkant, Robert A

AU - Fogarty, Zachary C

AU - Block, Matthew S

AU - Maurer, Matthew J

AU - Goergen, Krista M

AU - Fridley, Brooke L

AU - Cunningham, Julie M

AU - Rider, David N

AU - Preston, Claudia

AU - Hartmann, Lynn C

AU - Lawrenson, Kate

AU - Wang, Chen

AU - Tyrer, Jonathan

AU - Song, Honglin

AU - deFazio, Anna

AU - Johnatty, Sharon E

AU - Doherty, Jennifer A

AU - Phelan, Catherine M

AU - Sellers, Thomas A

AU - Ramirez, Starr M

AU - Vitonis, Allison F

AU - Terry, Kathryn L

AU - Van Den Berg, David

AU - Pike, Malcolm C

AU - Wu, Anna H

AU - Berchuck, Andrew

AU - Gentry-Maharaj, Aleksandra

AU - Ramus, Susan J

AU - Diergaarde, Brenda

AU - Shen, Howard

AU - Jensen, Allan

AU - Menkiszak, Janusz

AU - Cybulski, Cezary

AU - Lubiłski, Jan

AU - Ziogas, Argyrios

AU - Rothstein, Joseph H

AU - McGuire, Valerie

AU - Sieh, Weiva

AU - Lester, Jenny

AU - Walsh, Christine

AU - Vergote, Ignace

AU - Lambrechts, Sandrina

AU - Despierre, Evelyn

AU - Garcia-Closas, Montserrat

AU - Hogdall, Claus K

AU - Kjaer, Susanne K

AU - AOCS Group

PY - 2014/4

Y1 - 2014/4

N2 - The presence of regulatory T cells (Treg) in solid tumors is known to play a role in patient survival in ovarian cancer and other malignancies. We assessed inherited genetic variations via 749 tag single-nucleotide polymorphisms (SNP) in 25 Treg-associated genes (CD28, CTLA4, FOXP3, IDO1, IL10, IL10RA, IL15, 1L17RA, IL23A, IL23R, IL2RA, IL6, IL6R, IL8, LGALS1, LGALS9, MAP3K8, STAT5A, STAT5B, TGFB1, TGFB2, TGFB3, TGFBR1, TGRBR2, and TGFBR3) in relation to ovarian cancer survival. We analyzed genotype and overall survival in 10,084 women with invasive epithelial ovarian cancer, including 5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous carcinoma cases of European descent across 28 studies from the Ovarian Cancer Association Consortium (OCAC). The strongest associations were found for endometrioid carcinoma and IL2RA SNPs rs11256497 [HR, 1.42; 95% confidence interval (CI), 1.22-1.64; P = 5.7 × 10(-6)], rs791587 (HR, 1.36; 95% CI, 1.17-1.57; P = 6.2 × 10(-5)), rs2476491 (HR, = 1.40; 95% CI, 1.19-1.64; P = 5.6 × 10(-5)), and rs10795763 (HR, 1.35; 95% CI, 1.17-1.57; P = 7.9 × 10(-5)), and for clear cell carcinoma and CTLA4 SNP rs231775 (HR, 0.67; 95% CI, 0.54-0.82; P = 9.3 × 10(-5)) after adjustment for age, study site, population stratification, stage, grade, and oral contraceptive use. The rs231775 allele associated with improved survival in our study also results in an amino acid change in CTLA4 and previously has been reported to be associated with autoimmune conditions. Thus, we found evidence that SNPs in genes related to Tregs seem to play a role in ovarian cancer survival, particularly in patients with clear cell and endometrioid epithelial ovarian cancer.

AB - The presence of regulatory T cells (Treg) in solid tumors is known to play a role in patient survival in ovarian cancer and other malignancies. We assessed inherited genetic variations via 749 tag single-nucleotide polymorphisms (SNP) in 25 Treg-associated genes (CD28, CTLA4, FOXP3, IDO1, IL10, IL10RA, IL15, 1L17RA, IL23A, IL23R, IL2RA, IL6, IL6R, IL8, LGALS1, LGALS9, MAP3K8, STAT5A, STAT5B, TGFB1, TGFB2, TGFB3, TGFBR1, TGRBR2, and TGFBR3) in relation to ovarian cancer survival. We analyzed genotype and overall survival in 10,084 women with invasive epithelial ovarian cancer, including 5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous carcinoma cases of European descent across 28 studies from the Ovarian Cancer Association Consortium (OCAC). The strongest associations were found for endometrioid carcinoma and IL2RA SNPs rs11256497 [HR, 1.42; 95% confidence interval (CI), 1.22-1.64; P = 5.7 × 10(-6)], rs791587 (HR, 1.36; 95% CI, 1.17-1.57; P = 6.2 × 10(-5)), rs2476491 (HR, = 1.40; 95% CI, 1.19-1.64; P = 5.6 × 10(-5)), and rs10795763 (HR, 1.35; 95% CI, 1.17-1.57; P = 7.9 × 10(-5)), and for clear cell carcinoma and CTLA4 SNP rs231775 (HR, 0.67; 95% CI, 0.54-0.82; P = 9.3 × 10(-5)) after adjustment for age, study site, population stratification, stage, grade, and oral contraceptive use. The rs231775 allele associated with improved survival in our study also results in an amino acid change in CTLA4 and previously has been reported to be associated with autoimmune conditions. Thus, we found evidence that SNPs in genes related to Tregs seem to play a role in ovarian cancer survival, particularly in patients with clear cell and endometrioid epithelial ovarian cancer.

KW - Female

KW - Gene Expression

KW - Gene Expression Profiling

KW - Genetic Predisposition to Disease

KW - Genetic Variation

KW - Germ-Line Mutation

KW - Humans

KW - Interleukin-2 Receptor alpha Subunit

KW - Neoplasm Grading

KW - Neoplasm Invasiveness

KW - Ovarian Neoplasms

KW - Patient Outcome Assessment

KW - Polymorphism, Single Nucleotide

KW - Prognosis

KW - T-Lymphocytes, Regulatory

U2 - 10.1158/2326-6066.CIR-13-0136

DO - 10.1158/2326-6066.CIR-13-0136

M3 - Journal article

C2 - 24764580

VL - 2

SP - 332

EP - 340

JO - Cancer Immunology Research

JF - Cancer Immunology Research

SN - 2326-6066

IS - 4

ER -

ID: 138427571